Mechanical Wearable Injectors Segment by Products to Grow at Faster Pace during Forecast Period.
According to a new market research study of “Patient Controlled Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis - by Product, Application, Distribution Channel, and Geography”, the global patient controlled injectors market is expected to reach US$ 2,969.47 million by 2027 from US$ 7,505.70 million in 2019. The market is estimated to grow at a CAGR of 12.4% from 2020 to 2027. The report highlights trends prevailing in the global patient controlled injectors market and the factors driving market along with those that act as hindrances.
Based on product, the global patient controlled injectors market is segmented into electronic wearable injector, mechanical wearable injector, and infusion pumps. In 2019, the electronic wearable injectors segment held the largest share of the market; whereas, the mechanical wearable injectors segment is estimated to register the highest CAGR in the market during the forecast period. Factors such as rising adoption of mechanical injectors and emphasis on superior treatment outcomes are estimated to contribute to the mechanical wearable injectors segment growth.
The growth of the patient controlled injectors market is attributed to the factors such as increasing prevalence of chronic conditions and acceptance of patient controlled injectors due to better patient compliance. However, lack of awareness and adoption of patient controlled injectors in emerging countries is likely to restraint the growth of the market during the forecast period.
The demand for patient controlled injectors increased during the pandemic period. Factors such as increased patient population, shortage of healthcare resources, and ease of increased the adoption of injectors had positive impact on the market by certain extent. However, implementation of physical distancing policies and total shut down of businesses in order to prevent the viral infection disrupted the supply chain operations, which caused a negative impact on the market growth.
Gerresheimer AG; F. Hoffmann-La Roche Ltd.; Johnson and Johnson Services, Inc.; Ypsomed AG; Westbourne Medical Limited; Enable Injections; scPharmaceuticals Inc.; United Therapeutics Corporation; and BD are among the leading companies operating in the patient controlled injectors market.
The report segments Global Patient Controlled Injectors Market as follows:
By Product
By Application
By Distribution Channel
By Geography
Reasons to Buy:
According to a new market research study of “Patient Controlled Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis - by Product, Application, Distribution Channel, and Geography”, the global patient controlled injectors market is expected to reach US$ 2,969.47 million by 2027 from US$ 7,505.70 million in 2019. The market is estimated to grow at a CAGR of 12.4% from 2020 to 2027. The report highlights trends prevailing in the global patient controlled injectors market and the factors driving market along with those that act as hindrances.
Based on product, the global patient controlled injectors market is segmented into electronic wearable injector, mechanical wearable injector, and infusion pumps. In 2019, the electronic wearable injectors segment held the largest share of the market; whereas, the mechanical wearable injectors segment is estimated to register the highest CAGR in the market during the forecast period. Factors such as rising adoption of mechanical injectors and emphasis on superior treatment outcomes are estimated to contribute to the mechanical wearable injectors segment growth.
The growth of the patient controlled injectors market is attributed to the factors such as increasing prevalence of chronic conditions and acceptance of patient controlled injectors due to better patient compliance. However, lack of awareness and adoption of patient controlled injectors in emerging countries is likely to restraint the growth of the market during the forecast period.
The demand for patient controlled injectors increased during the pandemic period. Factors such as increased patient population, shortage of healthcare resources, and ease of increased the adoption of injectors had positive impact on the market by certain extent. However, implementation of physical distancing policies and total shut down of businesses in order to prevent the viral infection disrupted the supply chain operations, which caused a negative impact on the market growth.
Gerresheimer AG; F. Hoffmann-La Roche Ltd.; Johnson and Johnson Services, Inc.; Ypsomed AG; Westbourne Medical Limited; Enable Injections; scPharmaceuticals Inc.; United Therapeutics Corporation; and BD are among the leading companies operating in the patient controlled injectors market.
The report segments Global Patient Controlled Injectors Market as follows:
By Product
- Electronic Wearable Injector
- Mechanical Wearable Injector
- Infusion Pumps
By Application
- Cancer Treatment
- Auto-immune Treatment
- Blood Disorders Treatment
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Mail Order Pharmacies
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
- South & Central America (SCAM)
- Brazil
- Argentina
- Rest of South & Central America
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the patient controlled injectors market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global patient controlled injectors market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Patient Controlled Injectors Market - By Product
1.3.2 Global Patient Controlled Injectors Market - By Application
1.3.3 Global Patient Controlled Injectors Market - By Distribution Channel
1.3.4 Global Patient Controlled Injectors Market - By Geography
2. Patient Controlled Injectors Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Patient Controlled Injectors Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East & Africa - PEST Analysis
4.2.5 South & Central America - PEST Analysis
4.3 Expert Opinion
5. Patient Controlled Injectors Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Rising Patient Compliance
5.2 Market Restraints
5.2.1 Lack of Adoption in Emerging Countries
5.3 Market Opportunities
5.3.1 Technological Advancements and Design Development
5.4 Future Trends
5.4.1 Consolidation of Market
5.5 Impact Analysis
6. Patient Controlled Injectors Market - Global Analysis
6.1 Global Patient Controlled Injectors Market Revenue Forecast and Analysis
6.2 Global Patient Controlled Injectors Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Patient Controlled Injectors Market - By Product
7.1 Overview
7.2 Patient Controlled Injectors Market Share, by Product, 2019 and 2027 (%)
7.3 Electronic Injectors
7.3.1 Overview
7.3.2 Electronic Injectors: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
7.4 Mechanical Injectors
7.4.1 Overview
7.4.2 Mechanical Injectors: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
7.5 Infusion Pumps
7.5.1 Overview
7.5.2 Infusion Pumps: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
8. Patient Controlled Injectors Market - By Application
8.1 Overview
8.2 Patient Controlled Injectors Market Share, by Application, 2019 and 2027 (%)
8.3 Cancer Treatment
8.3.1 Overview
8.3.2 Cancer Treatment: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
8.4 Autoimmune Disease
8.4.1 Overview
8.4.2 Autoimmune Disease: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
8.5 Blood Disorders Treatment
8.5.1 Overview
8.5.2 Blood Disorder Treatment: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
9. Patient Controlled Injectors Market - By Distribution Channel
9.1 Overview
9.2 Patient Controlled Injectors Market Share, by Distribution Channel, 2019 and 2027 (%)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 Retail Pharmacies: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
9.5 Mail Order Pharmacies
9.5.1 Overview
9.5.2 Mail Order Pharmacies: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10. Patient Controlled Injectors Market - Geographic Analysis
10.1 North America: Patient Controlled Injectors Market
10.1.1 Overview
10.1.2 North America: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 North America Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
10.1.7 US: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.1.7.4 US Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Patient Controlled Injectors Market, by Products - Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.1.8.4 Canada Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Patient Controlled Injectors Market, by Products - Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.1.9.4 Mexico Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2 Europe: Patient Controlled Injectors Market
10.2.1 Overview
10.2.2 Europe: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.2.4 Europe Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.2.5 Europe Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2.6 Europe: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
10.2.7 Germany: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.2.7.3 Germany Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.2.7.4 Germany Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2.8 UK: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.2.8.3 UK Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.2.8.4 UK Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2.9 France: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.2.9.3 France Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.2.9.4 France Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2.10 Spain: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.2.10.3 Spain Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.2.10.4 Spain Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2.11 Italy: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.2.11.3 Italy Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.2.11.4 Italy Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2.12 Rest of Europe
10.2.12.1 Rest of Europe Patient Controlled Injectors Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.12.2 Rest of Europe Patient Controlled Injectors Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.12.3 Rest of Europe Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.2.12.4 Rest of Europe Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3 Asia Pacific: Patient Controlled Injectors Market
10.3.1 Overview
10.3.2 Asia Pacific: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia Pacific Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.3.4 Asia Pacific Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.3.5 Asia Pacific Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.6 Asia Pacific: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
10.3.7 China: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.3.7.3 China Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.3.7.4 China Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.8 Japan: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.3.8.3 Japan Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.3.8.4 Japan Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.9 India: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.3.9.3 India Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.3.9.4 India Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.10 South Korea: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.3.10.3 South Korea Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.3.10.4 South Korea Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.11 Australia: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Australia Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.3.11.3 Australia Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.3.11.4 Australia Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.12 Rest of Asia Pacific: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.12.1 Rest of Asia Pacific: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.12.2 Rest of Asia Pacific Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.3.12.3 Rest of Asia Pacific Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.3.12.4 Rest of Asia Pacific Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4 Middle East & Africa: Patient Controlled Injectors Market
10.4.1 Overview
10.4.2 Middle East & Africa: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (US$ Million)
10.4.3 Middle East & Africa Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.4.4 Middle East & Africa Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.4.5 Middle East & Africa Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4.6 Middle East & Africa: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
10.4.7 UAE: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.4.7.1 UAE: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.4.7.2 UAE Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.4.7.3 UAE Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.4.7.4 UAE Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4.8 Saudi Arabia: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.4.8.1 Saudi Arabia: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.4.8.2 Saudi Arabia Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.4.8.3 Saudi Arabia Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.4.8.4 Saudi Arabia Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4.9 South Africa: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.4.9.3 South Africa Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.4.9.4 South Africa Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4.10 Rest of Middle East and Africa: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.4.10.1 Rest of Middle East and Africa: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.4.10.2 Rest of Middle East and Africa Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.4.10.3 Rest of Middle East and Africa Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.4.10.4 Rest of Middle East and Africa Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.5 South and Central America: Patient Controlled Injectors Market
10.5.1 Overview
10.5.2 South and Central America: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.5.3 South and Central America Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.5.4 South and Central America Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.5.5 South and Central America Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.5.6 South and Central America: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.5.7.3 Brazil Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.5.7.4 Brazil Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.5.8 Argentina: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.5.8.3 Argentina Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.5.8.4 Argentina Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.5.9 Rest of South and Central America: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.5.9.1 Rest of South and Central America: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.5.9.2 Rest of South and Central America Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
10.5.9.3 Rest of South and Central America Patient Controlled Injectors Market, by Application - Revenue and Forecast to 2027(USD Million)
10.5.9.4 Rest of South and Central America Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11. Impact Of COVID-19 Pandemic on Global Patient Controlled Injectors Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment Of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Patient Controlled Injectors Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 West Pharmaceutical Services, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Sensile Medical AG (Gerresheimer AG)
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. HOFFMANN-LA ROCHE LTD.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Johnson and Johnson Services, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Ypsomed AG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Westbourne Medical Limited
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Enable Injections
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 scPharmaceuticals Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 United Therapeutics Corporation
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 BD
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of TermsList of Tables
Table 1. North America Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 2. North America Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 3. North America Patient Controlled Injectors Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 4. US Patient Controlled Injectors Market, by Product- Revenue and Forecast to 2027 (USD Million)
Table 5. US Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 6. US Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Patient Controlled Injectors Market, by Products - Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 9. Canada Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Patient Controlled Injectors Market, by Products - Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 12. Mexico Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 13. Europe Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 14. Europe Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 15. Europe Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 16. Germany Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 17. Germany Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 18. Germany Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 19. UK Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 20. UK Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 21. UK Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 22. Incidence, Mortality and Prevalence by cancer site, 2018, France
Table 23. France Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 24. France Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 25. France Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 26. Spain Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 27. Spain Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 28. Spain Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 29. Incidence, Mortality and Prevalence by cancer site, 2018, Italy
Table 30. Italy Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 31. Italy Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 32. Italy Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 33. Rest of Europe Patient Controlled Injectors Market Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 34. Rest of Europe Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
Table 35. Rest of Europe Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 36. Asia Pacific Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 37. Asia Pacific Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 38. Asia Pacific Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 39. China Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 40. China Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 41. China Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 42. Japan Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 43. Japan Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 44. Japan Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 45. India Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 46. India Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 47. India Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 48. South Korea Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 49. South Korea Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 50. South Korea Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 51. Australia Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 52. Australia Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 53. Australia Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 54. Rest of Asia Pacific Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 55. Rest of Asia Pacific Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
Table 56. Rest of Asia Pacific Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 57. Middle East & Africa Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 58. Middle East & Africa Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
Table 59. Middle East & Africa Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 60. UAE Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 61. UAE Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 62. UAE Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 63. Saudi Arabia Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 64. Saudi Arabia Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 65. Saudi Arabia Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 66. South Africa Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 67. South Africa Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 68. South Africa Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 69. Rest of Middle East and Africa Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 70. Rest of Middle East and Africa Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 71. Rest of Middle East and Africa Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 72. South and Central America Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 73. South and Central America Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027 (USD Million)
Table 74. South and Central America Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 75. Brazil Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 76. Brazil Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 77. Brazil Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 78. Argentina Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 79. Argentina Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 80. Argentina Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 81. Rest of South and Central America Patient Controlled Injectors Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 82. Rest of South and Central America Patient Controlled Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
Table 83. Rest of South and Central America Patient Controlled Injectors Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 84. Organic Developments Done By Companies
Table 85. Inorganic Developments Done By Companies
Table 86. Glossary of Terms, Patient Controlled Injectors MarketList of Figures
Figure 1. Patient Controlled Injectors Market Segmentation
Figure 2. Patient Controlled Injectors Segmentation, By Region
Figure 3. Global Patient Controlled Injectors Market Overview
Figure 4. Electronic Wearable Injector Segment Held Largest Share of Patient Controlled Injectors Market
Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period
Figure 6. Patient Controlled Injectors Market, by Geography (US$ Million)
Figure 7. Global Patient Controlled Injectors Market - Leading Country Markets (US$ Million)
Figure 8. Global Patient Controlled Injectors Market, Industry Landscape
Figure 9. North America : PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Patient Controlled Injectors Market Impact Analysis of Driver and Restraints
Figure 15. Global Patient Controlled Injectors Market - Revenue Forecast and Analysis - 2019- 2027
Figure 16. Global Patient Controlled Injectors Market - By Geography Forecast and Analysis - 2019- 2027
Figure 17. Market Positioning Of Key Players In Global Patient Controlled Injectors Market
Figure 18. Patient Controlled Injectors Market Share, by Product, 2019 and 2027 (%)
Figure 19. Electronic Injectors: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
Figure 20. Mechanical Injectors: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
Figure 21. Infusion Pumps: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
Figure 22. Patient Controlled Injectors Market Share, by Application, 2019 and 2027 (%)
Figure 23. Cancer Treatment: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
Figure 24. Autoimmune Disease: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
Figure 25. Blood Disorder Treatment: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
Figure 26. Others: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
Figure 27. Patient Controlled Injectors Market Share, by End user, 2019 and 2027 (%)
Figure 28. Hospital Pharmacies: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
Figure 29. Retail Pharmacies: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
Figure 30. Mail Order Pharmacies: Patient Controlled Injectors Market- Revenue and Forecast to 2027 (USD Million)
Figure 31. North America: Patient Controlled Injectors Market, by Key Country - Revenue (2019) (USD Million)
Figure 32. North America Patient Controlled Injectors Market Revenue and Forecast to 2027 (USD Million)
Figure 33. North America: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
Figure 34. US: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 35. Canada: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 36. Mexico: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 37. Europe: Patient Controlled Injectors Market, by Key Country - Revenue (2019) (USD Million)
Figure 38. Europe Patient Controlled Injectors Market Revenue and Forecast to 2027 (USD Million)
Figure 39. Europe: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
Figure 40. Germany: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 41. UK: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 42. France: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 43. Spain: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 44. Italy: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 45. Rest of Europe Patient Controlled Injectors Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 46. Asia Pacific: Patient Controlled Injectors Market, by Key Country - Revenue (2019) (USD Million)
Figure 47. Asia Pacific Patient Controlled Injectors Market Revenue and Forecast to 2027 (USD Million)
Figure 48. Asia Pacific: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
Figure 49. China: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 50. Japan: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 51. India: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 52. South Korea: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 53. Australia: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 54. Rest of Asia Pacific: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 55. Middle East & Africa: Patient Controlled Injectors Market, by Key Country - Revenue (2019) (USD Million)
Figure 56. Middle East & Africa Patient Controlled Injectors Market Revenue and Forecast to 2027 (USD Million)
Figure 57. Middle East & Africa: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
Figure 58. UAE: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 59. Saudi Arabia: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 60. South Africa: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 61. Rest of Middle East and Africa: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 62. South and Central America: Patient Controlled Injectors Market, by Key Country - Revenue (2019) (USD Million)
Figure 63. South and Central America Patient Controlled Injectors Market Revenue and Forecast to 2027 (USD Million)
Figure 64. South and Central America: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
Figure 65. Brazil: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 66. Argentina: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 67. Rest of South and Central America: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (USD Million)
Figure 68. Impact of COVID-19 Pandemic in North American Country Markets
Figure 69. Impact of COVID-19 Pandemic in European Country Markets
Figure 70. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 71. Impact Of COVID-19 Pandemic in Middle East and Africa Market
Figure 72. Impact Of COVID-19 Pandemic in South and Central America Market
Figure 73. Growth Strategies Done by the Companies in the Market, (%)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- West Pharmaceutical Services, Inc.
- Gerresheimer AG
- F. HOFFMANN-LA ROCHE LTD.
- Johnson and Johnson Services, Inc.
- Ypsomed AG
- Westbourne Medical Limited
- Enable Injections
- scPharmaceuticals Inc.
- United Therapeutics Corporation
- BD
